Together, these data indicate that the absence of myeloid NF‐κB p50 augments the activity of T‐cell checkpoint blockade to increase T‐cell infiltration or expansion, as well as T‐cell activation, to slow high‐risk neuroblastoma tumor growth. Here, NFKB1 is linked to neoplasm.